Medical Minutes Thread Two

The “Silent Tsunami” Preparedness Playbook: Addressing Disparities and Evolving Therapies in NASH and NAFLD

Faculty

Atoosa Rabiee, MD

Chief of Transplant Services Assistant Professor of Medicine

Director of Hepatology

Division of Gastroenterology and Hepatology

Washington DC VA Medical Center

Washington DC


Anand Shah, MD

Assistant Professor of Medicine and Director of Liver Transplant

Washington DC VA Medical Center

Washington DC


Jessica P.E. Davis, MD, MSCR

Anand Shah, MD

Assistant Professor

Division of Digestive Diseases

Emory University School of Medicine

Director of Hepatology

Joseph Maxwell Cleland

Atlanta VA Medical Center

Atlanta, GA


Program Overview

The incidence of NASH is increasing globally along with increases in obesity, type 2 diabetes, and metabolic syndrome. With these increases, it is critical that healthcare providers can determine the risk of their patients for developing non-alcoholic fatty liver disease (NAFLD) and assess the risk of progression to NASH. Lifestyle and sociodemographic factors play an important role in the disparities of NAFLD. Significant advances have been made in the understanding of NAFLD/NASH pathophysiology, risk factors, and disease progression, leading to newer diagnostic approaches and therapeutic targets. However, navigating these developments is no easy feat. 

This program is designed to bring forward cutting-edge perspectives to the diagnosis and management of NAFLD/NASH, as well to as highlight multi-disciplinary solutions that are ultimately needed to improve outcomes.

Learning Objectives

Upon completion of this activity, the participant should be able to:

•Discuss the development of NASH including the management and clinical outcomes in patients
•Summarize the SDoH impact factors that influence risk, disease progression and complications of NASH/NAFLD 
•Evaluate current and emerging treatment options for patients with NASH based on clinical trial results 

Accreditation

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Iridium Continuing Education (Iridium). Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This educational activity for 0.25 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must:
  • Read the learning objectives and faculty disclosures
  • Complete the pretest
  • View the broadcast
  • Complete the posttest with a score of 70% or higher

A statement of credit will be issued within four weeks of receipt of a completed activity evaluation form.

Fee Information and Refund/Cancellation Policy

There is no fee for this educational activity.

Contact Information

For information about the accreditation of this program, please contact Global at 303-395-1782 or [email protected]

Disclosures

Disclosures of Relevant Financial Relationships

Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.

All relevant financial relationships have been mitigated.

The faculty have the following relevant financial relationships with ineligible companies:

Atoosa Rabiee, MD, Anand Shah, MD, and Jessica P.E. Davis, MD, MSCR have no relevant financial relationships with ineligible companies to disclose.

The following planners and managers involved in the development of this activity have no relevant financial relationships with ineligible companies to disclose.

Global
The planners and managers at Global Education Group have no relevant financial relationships to disclose.

Iridium
Iridium staff and others involved with the planning, development, and review of the content for this activity have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and Iridium do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
This activity is jointly provided by Global Education Group and Iridium Continuing Education.
SUPPORTER ACKNOWLEDGEMENT
This educational activity is supported by an educational grant from Intercept Pharmaceuticals, Inc, 

Credit Amount: 0.25

Credit Type: AMA
Release: June 15, 2023
Expiration: June 15, 2024